PERCEPTIVE ADVISORS LLC

Position in CTMX — CytomX Therapeutics, Inc.

CIK 1224962 NEW YORK, NY

Position in CTMX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$39,146,943

-$8,317,529 QoQ

Shares Held

10,439,185

+3.4% QoQ

Ownership

4.79%

of shares outstanding

% of Portfolio

0.63%

of 13F equity value

Holder Rank

of 178 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PERCEPTIVE ADVISORS LLC holds $5,486,611,234 across 68 Biotechnology names. CTMX ranks #31 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PRAX	Praxis Precision Medicines, Inc.	2,035,986	$681,627,752
2	SYRE	Spyre Therapeutics, Inc.	4,319,496	$383,484,854
3	CELC	Celcuity Inc.	3,197,200	$334,491,064
4	ASND	Ascendis Pharma A/S	1,163,721	$310,387,665
5	RYTM	Rhythm Pharmaceuticals, Inc.	2,586,295	$287,156,333
6	ROIV	Roivant Sciences Ltd.	8,085,461	$286,144,464
7	RLAY	Relay Therapeutics, Inc.	14,106,187	$263,926,758
8	TVTX	Travere Therapeutics, Inc.	3,752,574	$213,183,728

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$39,146,943	10,439,185	+3.4%	Shares	Sole	2026-08-14
2026-03-31	$47,464,472	10,098,824	+4.3%	Shares	Sole	2026-05-29
2025-12-31	$41,237,588	9,680,185	0.0%	Shares	Sole	2026-02-17
2025-09-30	$30,879,790	9,680,185	+38.4%	Shares	Sole	2025-11-14
2025-08-14	$17,037,125	9,680,185	—	Shares	Sole	2025-08-21
2025-06-30	$15,875,576	6,993,646	+326.2%	Shares	Sole	2025-08-14
2021-06-30	$10,387,257	1,640,957	-23.8%	Shares	Sole	2021-08-16
2021-03-31	$16,650,219	2,153,974	-16.4%	Shares	Sole	2021-08-13
2020-12-31	$16,879,631	2,577,043	0.0%	Shares	Sole	2021-02-16
2020-09-30	$17,137,335	2,577,043	0.0%	Shares	Sole	2020-11-16
2020-06-30	$21,466,768	2,577,043	-20.8%	Shares	Sole	2020-08-17
2020-03-31	$24,957,589	3,253,923	—	Shares	Sole	2020-05-18
No filing history on record for this holder in this stock.